期刊文献+

容量滴定法测定去羟肌苷含量的分析方法验证与认可 被引量:2

Methodological verification and approval of the volumetric titration determination of didanosine
原文传递
导出
摘要 目的:建立容量滴定法测定去羟肌苷的含量。方法:采用非水溶液滴定法,以冰醋酸-醋酐混合溶液(4∶1)为滴定介质,电位滴定指示终点,每次加液体积为0.05 m L,等当点突跃幅度EPC设定为30,进行含量测定,并对分析方法进行验证,具体阐述了容量滴定法的方法验证过程和验证结果的认可标准。结果:去羟肌苷测定的成比例系统误差、额外系统误差及精密度均符合规范要求。结论:本法经方法学验证,可用于去羟肌苷原料的含量测定。 Objective:To establish a volumetric titration method for determination of didanosine.Methods:The non-water determination method was established for the content of didanosine with 40 m L glacial acetic acid and 10 m L anhydride acetic acid as the titration medium,the end point was determined potentiometrically,the volume step was 0.05 m L and EPC was set at 30.The established method was used for content determination and the analytical method was verified.The procedures and approval criteria of volumetric titration for determination of didanosine was described in this article.Results:The good proportional systematic,the additional proportional systematic and the statistical error acquired in this method met the requirement of related standards.Conclusion:It is proved that the method can be applied for the determination of dianosine by the methodology validation.
作者 连莹 仲平
出处 《药物分析杂志》 CAS CSCD 北大核心 2015年第6期1110-1114,共5页 Chinese Journal of Pharmaceutical Analysis
基金 中国全球基金TB结核病项目卫生系统加强(HSS)药品质量标准提高项目(2010-2013)
关键词 去羟肌苷 核苷类逆转录酶抑制剂 双去氧三磷酸腺苷(dd ATP) 容量滴定法 电位滴定 方法验证 didanosine nucleoside reverse transcriptase inhibitor dd ATP volume titration potentiometric titration methodological verification
  • 相关文献

参考文献5

二级参考文献27

  • 1国家食品药品监督管理局.化学药物质量控制分析方法验证技术指导原则[S].2005 被引量:3
  • 2国家食品药品监督管理局.化学药品杂质研究的技术指导原则[S].2005. 被引量:1
  • 3Carr A,Samaras K,Burton S,et al.Asyndrome of peripheral lipodystrophy,hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors[J].AIDS,1998,12(7):F51-F58. 被引量:1
  • 4石饶忠.艾滋病·实用内科学[M].第11版,北京:人民卫生出版社,2001.388-395. 被引量:1
  • 5[1]Chu CK,Bhadti VS,Doboszewski B,et al.General syntheses of dideoxynucleosides and 2′,3′-didehydro-2′,3′-dideoxynucleosides[J].J Org Chem,1989,54:2217-2225. 被引量:1
  • 6[2]Amino Y,lwagami T.A.Preparation of 2′,3′-deoxyinosine as virucide[P].JP:02164895(90164 895),1990-06-25.(CA 1990,114:P7095r) 被引量:1
  • 7[3]Shiragaml H,Arai M,Izawa K,et al.Method of purifying nucleoside derivatives[P]: EP:0582157(92199964),1994-02-09.(CA 1994,121:P134700d) 被引量:1
  • 8[4]Antonov KV,Konstantinova ID,Miroshnikov AI.New approach to the synthesis of 2′,3′-dideoxyade-nosine and 2′,3′-dideoxyinosine[J].Nucleosides Nucleotides,1998,17:153-159. 被引量:1
  • 9[5]Yoshioka H,Kojima F,Ishida S,et al.Preparation of 2′,3′-dideoxypurine nucleosides as antiviral agents[P].JP:88-240876,1990-03-30.(CA 1990,113:P132718b) 被引量:1
  • 10[6]Shiragamy H,Amino Y,Honda Y,et al.Synthesis of 2′,3′-dideoxypurinenucleosides via the palladium catalyzed reduction of 9-(2,5-di- O -acetyl-3-bromo-3-deoxy-β-xylofuranosyl) purine derivatives[J].Nucleosides Nucleotides,1996,15(1-3):31-45. 被引量:1

共引文献27

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部